Medication may stop drug and alcohol addiction

June 23, 2015, University of Texas at Austin
Hitoshi Morikawa and his team have discovered that an FDA-approved antihypertensive drug can stop cocaine or alcohol addiction in rats. Credit: University of Texas at Austin

Researchers at The University of Texas at Austin have successfully stopped cocaine and alcohol addiction in experiments using a drug already approved by the U.S. Food and Drug Administration (FDA) to treat high blood pressure. If the treatment is proven effective in humans, it would be the first of its kind—one that could help prevent relapses by erasing the unconscious memories that underlie addiction.

The research is published this week in the journal Molecular Psychiatry.

Scientists once believed that drug was simply a physical craving: Drug addicts who became sober and then later relapsed merely lacked willpower. But that view has gradually shifted since the 1970s.

Today, most experts acknowledge that environmental cues—the people, places, sights and sounds an addict experiences leading up to drug use—are among the primary triggers of relapses. It was an environmental cue (a ringing bell) that caused the dogs in Ivan Pavlov's famous experiments to salivate, even when they couldn't see or smell food.

Led by Hitoshi Morikawa, associate professor of neuroscience at The University of Texas at Austin, a team of researchers trained rats to associate either a black or white room with the use of a drug. Subsequently, when the addicted rats were offered the choice of going into either room, they nearly always chose the room they associated with their addiction.

Then one day, the researchers gave the addicted rats a high dose of an antihypertensive drug called isradipine before the rats made their choices. Although rats still preferred the room they associated with their addiction on that day, they no longer showed a preference for it on subsequent days. In fact, the lack of preference persisted in the isradipine-treated group in ways that couldn't be found in a control group—suggesting the addiction memories were not just suppressed but had gone away entirely.

"The isradipine erased memories that led them to associate a certain room with cocaine or alcohol," said Morikawa.

Addictive drugs are thought to rewire brain circuits involved in reward learning, forming powerful memories of drug-related cues. Antihypertensive drugs all block a particular type of ion channel, which is expressed not only in heart and blood vessels but also in certain brain cells. The researchers found that blocking these ion channels in brain cells, using isradipine, appears to reverse the rewiring that underlies memories of addiction-associated places.

There are already medications that have been shown to prevent people from feeling euphoria when they take an addictive drug and that might prevent them from developing an addiction. A treatment based on this latest research, however, would be much more effective, said Morikawa, targeting the associations an addict has with the experience leading up to taking a drug.

"Addicts show up to the rehab center already addicted," he said. "Many addicts want to quit, but their brains are already conditioned. This might help the addicted brain become de-addicted."

Morikawa noted that because isradipine is already labeled as safe for human use by the FDA, clinical trials could potentially be carried out much more quickly than with nonapproved drugs.

One challenge with using isradipine in high doses to treat addiction is that it lowers blood pressure. So it might be necessary to pair it with other treatments that prevent from falling too low.

Explore further: Serotonin makes some people more susceptible to drug dependence than others

More information: "L-type Ca2+ channel blockade with antihypertensive medication disrupts VTA synaptic plasticity and drug-associated contextual memory," Molecular Psychiatry (June 23, 2015): nature.com/doifinder/10.1038/MP.2015.84

Related Stories

Serotonin makes some people more susceptible to drug dependence than others

December 5, 2014
A study by Sarah Bradbury, who graduates with a PhD in Psychology next week, shows that the development of drug addiction is related to brain levels of serotonin—a chemical created by the human body that is responsible ...

Paradigm shift in treatment of addiction holds promise, thanks to epigenetics

May 26, 2015
One of the major challenges of cocaine addiction is the high rate of relapse after periods of withdrawal and abstinence. But new research reveals that changes in our DNA during drug withdrawal may offer promising ways of ...

Researchers see way cocaine hijacks memory

March 10, 2015
Washington State University researchers have found a mechanism in the brain that facilitates the pathologically powerful role of memory in drug addiction. Their discovery opens a new area of research for targeted therapy ...

Discovery of new neural pathway may lead to preventing relapses in addicts

June 18, 2015
Researchers at the University at Buffalo have discovered a previously unknown neural pathway that can regulate changes made in the brain due to cocaine use, providing new insight into the molecular basis of cocaine addiction. ...

Alcohol helps the brain remember, says new study

April 12, 2011
Drinking alcohol primes certain areas of our brain to learn and remember better, says a new study from the Waggoner Center for Alcohol and Addiction Research at The University of Texas at Austin.

Cocaine changes the brain and makes relapse more common in addicts

April 28, 2015
Cocaine use causes 'profound changes' in the brain that lead to an increased risk of relapse due to stress - according to new research from the University of East Anglia.

Recommended for you

Study shows how bias can influence people estimating the ages of other people

October 17, 2018
A trio of researchers from the University of New South Wales and Western Sydney University has discovered some of the factors involved when people make errors in estimating the ages of other people. In their paper published ...

Infants are more likely to learn when with a peer

October 16, 2018
Infants are more likely to learn from on-screen instruction when paired with another infant as opposed to viewing the lesson alone, according to a new study.

Researchers use brain cells in a dish to study genetic origins of schizophrenia

October 16, 2018
A study in Biological Psychiatry has established a new analytical method for investigating the complex genetic origins of mental illnesses using brain cells that are grown in a dish from human embryonic stem cells. Researchers ...

Income and wealth affect the mental health of Australians, study shows

October 16, 2018
Australians who have higher incomes and greater wealth are more likely to experience better mental health throughout their lives, new research led by the Bankwest Curtin Economics Centre has found.

Study suggests biological basis for depression, anxiety, sleep disturbances in older adults

October 15, 2018
UC San Francisco researchers, in collaboration with the unique Brazilian Biobank for Aging Studies (BBAS) at the University of São Paulo, have shown that the earliest stages of the brain degeneration associated with Alzheimer's ...

Linguistic red flags from Facebook posts can predict future depression diagnoses

October 15, 2018
In any given year, depression affects more than 6 percent of the adult population in the United States—some 16 million people—but fewer than half receive the treatment they need. What if an algorithm could scan social ...

2 comments

Adjust slider to filter visible comments by rank

Display comments: newest first

LaPortaMA
not rated yet Jun 23, 2015
http://www.imdb.c...0338013/
We have all been here before. We have all been here before.
Jim4321
5 / 5 (1) Jun 23, 2015
Isradipine is a calcium channel blocker. If memory erasure is a class effect -- what are the implications for the use of calcium channel blockers in the elderly? Is there an association between their use and Alzheimer's or normal cognitive decline with aging? Calcium channel blockers are well known to moderate mood swings and are sometimes prescribed for bipolar patients. Thus they are known to be psychoactive. The research presented in this press release needs to be followed up.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.